• Pfizer Inc. (PFE)'s Torisel Fails Phase III Renal Cell Carcinoma Study in Showdown Against Bayer HealthCare (BAY)'s Nexavar More...

• Newron Pharmaceuticals (NWRN) PD Drug Succeeds in Phase III, $26 Million Zambon Pact Sealed More...

• Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) More...

• Cytomedix Inc. (CMXI) Announces Expansion of Phase 2 Study to Treat Post-Acute Ischemic Stroke at Up to 15 U.S. Clinical Sites More...

• Baxter International, Inc. (BAX) Announces ADVATE Approval in China for the Treatment of Hemophilia A More...

• Why Both Men and Women View Women in Sexy Ads as Objects, Not Humans, Universite Libre de Bruxelles Study More...

• Girls Take Longer to Heal From Concussions, Michigan State University Study More...

• Looks Matter More Than Reputation When It Comes to Trusting People With Our Money, University of Warwick Study More...

• Two-Drug Combo Helps Teens With Migraines, GlaxoSmithKline (GSK) Reveals More...

• Feeding Tube May Flare Some Ulcer Risks, Brown University Study More...

• Star Scientific , Inc. Announces Patent Claims for Synthesis of Anatabine Granted by US PTO More...

• Oramed Pharmaceuticals Inc. (ORMP.OB) Granted Israeli Patent for Its Core Technology in Oral Delivery of Proteins More...

• USPTO Grants Codexis, Inc. (CDXS) Patent for Enzymes Used in Hep-C Therapeutics More...

• National Institute for Clinical Excellence (NICE) Reverses Earlier Decision, Backs Johnson & Johnson (JNJ)'s Zytiga More...

• Bristol-Myers Squibb Company (BMY)' Plavix's New Generic Status Could be Boon for Patients More...

• Amneal Pharmaceuticals Upgrades Generic Metformin Family by Listening to Customers More...

• Pfizer Inc. (PFE) Axes 50 Jobs More...

• Ra Pharmaceuticals Closes $8.6 Million Second Tranche of $27 Million Series A More...

• NuMe Health Completes $1.5 Million Series A Financing to Advance Its First Cobiotic™ Aimed at Helping Prediabetics Maintain Healthy Blood Glucose Levels More...

• Piramal Healthcare Limited to Buy US Drug Data Firm for $635 Million More...

• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Open to More M&A Deals More...

• GlaxoSmithKline (GSK) Completes Transaction to Increase Its Ownership in Theravance, Inc. (THRX) More...

• Intuitive Bio Acquires Assets of GenTel BioSciences, Inc. More...

• Newron Pharmaceuticals (NWRN) PD Drug Succeeds in Phase III, $26 Million Zambon Pact Sealed More...

• Plexpress Announces Collaboration With Admescope More...

• Avalanche Biotechnologies, Inc. and Lonza Inc. Announce Global Manufacturing Collaboration for Adeno-associated Viral Vectors for Gene Therapy More...

• Fibrocell Science, Inc. Announces Exclusive License Agreement with University of California, Los Angeles (UCLA) on Dermal Cell Research to Advance the Development of Personalized Cell Therapies More...

• The Biodesign Institute at Arizona State University Taps HighRes Biosolutions for Simplifying Upstream Sample Preparation of Protein Microarrays More...

• Boudazin Named President and CEO of Boiron More...

• Epizyme Announces Appointment of Eric Hedrick, M.D., as Chief Medical Officer More...

• Verdezyne, Inc. Names Ray W. Miller as Chief Business Officer More...

• DNAnexus, Inc. Appoints Marc Olesen as President and COO More...

• Applied DNA Sciences, Inc. (APDN) Reports Fiscal Second Quarter 2012 Results More...

• Aoxing Pharmaceutical Company Inc. (AXN) Announces Third Quarter Fiscal 2012 Financial and Operational Results More...

• Angiotech Pharmaceuticals, Inc. (ANPI) Announces Financial Results for the First Quarter Ended March 31, 2012 More...

• Cytomedix Inc. (CMXI) Reports First Quarter 2012 Financial Results More...

• Catalyst Pharmaceutical Research Announces First Quarter 2012 Financial Results More...

• Viropro Inc. (VPRO) to Unlock Value from its Biosimilars Portfolio; Creates a Biosimilars Technology Subsidiary in Canada More...